-
February 25: The Week in Cancer News
Screening program reduces disparities in colorectal cancer, and seeing the challenges of getting cancer care through one woman’s story.
by Eric Fitzsimmons
-
February 18: The Week in Cancer News
Aspirin is ineffective in preventing breast cancer recurrence, and immunotherapy holds promise for some patients with advanced anal cancer.
by Kevin McLaughlin
-
February 11: The Week in Cancer News
Millions miss cancer screenings, and commercial tobacco ban goes into effect for Navajo Nation after years of failed attempts.
by Marci A. Landsmann
-
February 4: The Week in Cancer News
CAR T-cell therapy effects continue 10 years after treatment and first T-cell receptor therapeutic approved for uveal melanoma.
by Eric Fitzsimmons
-
January 28: The Week in Cancer News
Pharmacies asked to stop turning immune-compromised people away for fourth shot, and fiber intake is associated with stronger immune response in people with melanoma.
by Marci A. Landsmann
-
January 21: The Week in Cancer News
Metastatic cancer patients nearing death continue to receive high-dose radiation despite guidelines advising against it, and new standards are likely to reduce racial disparities in lung cancer screening.
by Kevin McLaughlin
-
January 14: The Week in Cancer News
Cancer mortality continues to go down, and a “real-world” study finds more than a third of active surveillance patients are lost to follow-up.
by Eric Fitzsimmons
-
January 7: The Week in Cancer News
Three out of four people with advanced colorectal cancer suffer significant financial hardship, and lung cancer patients who quit smoking experience increased survival.
by Marci A. Landsmann
-
December 17: The Week in Cancer News
FDA approves drug to prevent graft versus host disease and decline in lung cancer deaths linked to screening.
by Kevin McLaughlin
-
December 10: The Week in Cancer News
A new program specializes in concerns of gay and bisexual men with prostate cancer, and Black women found to have a higher risk of lymphedema after breast cancer.
by Eric Fitzsimmons
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore